| Class 2 Device Recall Biomerieux | |
Date Initiated by Firm | March 23, 2018 |
Create Date | June 12, 2018 |
Recall Status1 |
Terminated 3 on June 23, 2020 |
Recall Number | Z-2172-2018 |
Recall Event ID |
80111 |
Product Classification |
Discs, strips and reagents, microorganism differentiation - Product Code JTO
|
Product | Oxidase Reagent (ref: 55635): This test is used to detect the production of the enzyme cytochrome oxidase by bacteria. This enzyme is characteristic of the genus Neisseria and most species of Pseudomonas. It enables the differentiation of Gram (-) bacilli (1, 2).
A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease. |
Code Information |
Oxidase Reagent (ref: 55635): Lot number 92366601 |
Recalling Firm/ Manufacturer |
BioMerieux SA Chemin De L'Orme Marcy L'Etoile France
|
Manufacturer Reason for Recall | A shipment to Guadeloupe suffered a temperature excursions up to 47.8C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioMrieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers. |
FDA Determined Cause 2 | Environmental control |
Action | The firm, Biomerieux, sent an "Urgent product removal notice" letter on April 23 to affected customers. The letter described the product, problem and actions to be taken. The customers were instructed to do the following:
1. Immediately acknowledge receipt (AR) of this FSCA.
2. Identify all countries and customers for which you are responsible that are impacted by this FSCA.
3. Define additional actions required (e.g. Translate customer letter, send to impacted countries/customers, etc.)
4. Distribute the customer letter to all customers that have received the products
5. Discard any impacted product remaining in local inventory
6. After all actions above are complete, please return the acknowledgement of completion (AC) for this FSCA. The due date for completion of the required actions and submitting the AC is 23-APR-2018
Subsidiaries
Subsidiaries using SAP, please manage both the Acknowledgment of Receipt and the Acknowledgment of Completion of activities in SAP.
Subsidiaries not using SAP, please immediately upload the Acknowledgement of Receipt in LiveLink after signing and completing sections #1 and #2. Section #3 must be signed, completed and uploaded in LiveLink before the due date.
Distributors
Please immediately Acknowledge Receipt of this FSCA by completing sections #1 and #2 of the acknowledgement form and sending it by email to fieldactions@biomerieux.com or by fax to +33 4 78 87 21 79. Please remember to sign and complete all of sections #1 and #2.
Sections #1 and #3 must be signed, completed, faxed or emailed before the due date.
If you have any questions, contact the Specialist, Regulatory & Quality Compliance at +33 4 78 87 56 16 or email to: charlotte.thollet@ext.biomerieux.com. |
Quantity in Commerce | 4 boxes of OXIDASE REAGENT with 50 - 0.75ML bottles |
Distribution | International distribution. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|